Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
71
天
Hypoxia‐inducible factor 2α inhibition in renal cell carcinoma: From von Hippel–Lindau biology to targeted therapeutics
作者
Yu‐Wei Chen; Fumika Sano; Rana R. McKay展开收起
作者单位
1. Division of Medical Oncology University of California, San Diego Moores Cancer Center San Diego California USA; 2. University of California, San Diego School of Medicine San Diego California USA展开收起
111
天
Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies
作者
Cuipeng Qiu; Claus Høgdall; Hailing Yang; Wei‐Lei Yang; Tim S. Poulsen; Karen S. Anderson; Zhen Lu; Robert C. Bast; Estrid Høgdall展开收起
作者单位
1. Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston Texas USA; 2. Department of Gynecology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark; 3. Molecular Unit Department of Pathology Herlev Hospital University of Copenhagen Herlev Denmark; 4. Biodesign Institute Arizona State University Tempe Arizona USA展开收起
225
天
Integration of individual‐level social determinants of health and associations with cardiovascular risk factors in breast and prostate cancer
作者
Wonyoung Jung; Gary Hettinger; Vivek Narayan; Lin Mei; Samuel Takvorian; Yehoda M. Martei; Amy Clark; Anran Huang; Kellie Mcdermott; Amanda M. Smith; Congying Xia; Kyunga Ko; Javier Sierra Pagan; Daniel Koropeckyj‐Cox; Kelly Getz; Carmen E. Guerra; Oluwadamilola M. Fayanju; Sanchit Kumar; Kirsten M. M. Beyer; Tiffany Powell‐Wiley; Clyde Yancy; Yong‐Moon Mark Park; Bonnie Ky展开收起
作者单位
1. Division of Cardiology Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 2. Thalheimer Center for Cardio‐Oncology Abramson Cancer Center Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 3. Department of Population Health New York University Grossman School of Medicine New York New York USA; 4. Division of Hematology and Oncology Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 5. Department of Internal Medicine Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 6. Department of Biostatistics, Epidemiology and Informatics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 7. Division of General Internal Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 8. Department of Surgery Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 9. Institute for Health and Humanity Medical College of Wisconsin Milwaukee Wisconsin USA; 10. Social Determinants of Obesity and Cardiovascular Risk Laboratory Cardiovascular Branch Division of Intramural Research National Heart, Lung, and Blood Institute National Institutes of Health Bethesda Maryland USA; 11. Intramural Research Program National Institute on Minority Health and Health Disparities National Institutes of Health Bethesda Maryland USA; 12. Department of Internal Medicine Division of Cardiology Feinberg School of Medicine Northwestern University Chicago Illinois USA; 13. Department of Epidemiology Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences Little Rock Arkansas USA; 14. Cancer Prevention and Population Sciences Research Program Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA展开收起
56
天
Biomarker use in the prostate cancer screening pathway: Maps of the evidence
作者
Rita L. Shiau; Jessica C. Griffin; Clarissa A. B. Troutman; Rose Relevo; Karli K. Kondo展开收起
作者单位
1. Center for Early Cancer Detection American Cancer Society Atlanta Georgia USA; 2. Research Integrity Oregon Health & Science University Portland Oregon USA展开收起
87
天
Prostate‐specific antigen‐based screening for prostate cancer: A systematic review to inform an American Cancer Society guideline
作者
Jessica C. Griffin; Rita L. Shiau; Clarissa A. B. Troutman; Alanna Welsh; Emily Edwards; Ibironke A. Ajayi; Rose Relevo; Karli K. Kondo展开收起
作者单位
1. Center for Early Cancer Detection American Cancer Society Atlanta Georgia USA; 2. Research Integrity Oregon Health & Science University Portland Oregon USA展开收起
127
天
Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients
作者
Monica Sarker; Zhengyi Deng; Eric C. Kauffman; Li Tang; Marilyn L. Kwan; Marvin E. Langston; Sumati Gupta; G. Daniel Grass; Eric A. Singer; Yousef Zakharia; Paul V. Viscuse; Laura Graham; Saum Ghodoussipour; Bodour Salhia; Sean Q. Kern; Adanma Ayanambakkam; Zin Myint; Jennifer King; Seyi Oderinde; Michelle L. Churchman; Robert J. Rounbehler; Ken Batai展开收起
作者单位
1. Department of Cancer Prevention and Control Roswell Park Comprehensive Cancer Center Buffalo New York USA; 2. Department of Urology Stanford University School of Medicine Stanford California USA; 3. Department of Epidemiology Stanford University Palo Alto California USA; 4. Department of Urology Roswell Park Comprehensive Cancer Center Buffalo New York USA; 5. Division of Research Kaiser Permanente Northern California Pleasanton California USA; 6. Huntsman Cancer Institute Salt Lake City Utah USA; 7. H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA; 8. Department of Urology Ohio State University Columbus Ohio USA; 9. University of Iowa Holden Comprehensive Cancer Center Iowa City Iowa USA; 10. Division of Hematology/Oncology University of Virginia Comprehensive Cancer Center Charlottesville Virginia USA; 11. University of Colorado Anschutz Medical Campus Aurora Colorado USA; 12. Rutgers Cancer Institute of New Jersey New Brunswick New Jersey USA; 13. Norris Comprehensive Cancer Center and Keck School of Medicine of the University of Southern California Los Angeles California USA; 14. Murtha Cancer Center Uniformed Services University of the Health Sciences Bethesda Maryland USA; 15. Stephenson Cancer Center University of Oklahoma Oklahoma City Oklahoma USA; 16. Markey Cancer Center University of Kentucky Lexington Kentucky USA; 17. Indiana University Simon Comprehensive Cancer Center Indianapolis Indiana USA; 18. Aster Insights Tampa Florida USA展开收起
FAQ
CANCER审稿要多久?
截至2026-11-17,CrushSCI 收录了 CANCER 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 41 天(GPRC5D‐targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies,2026-06-16 收稿,2026-07-27 录用),最慢一篇用了 237 天;平均 116.8 天,中位数 107 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
